Fradiomycin sulfate/Bacitracin

硫酸新霉素/杆菌肽

Report date: 2023/05/31 20:00:53

Base Information

Drug NameFradiomycin sulfate/Bacitracin
Drug Alias NameBIVATRACIN
ClassificationBiologics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCatheter-Related Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsYes Fradiomycin sulfateBacitracin
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesFuture University In Egypt
China Registration ClassN/A

Develop Information

Active CompaniesFuture University In Egypt
Inactive CompaniesN/A
Active IndicationsCatheter-Related Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A